A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients
Learn more about:
Related Clinical Trial
Intralesional HPV Vaccine for Condylomata
Safety Study of Multikine in the Treatment of Perianal Warts
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients
Recurrent and Nonrecurrent Condyloma Treatment
Effectiveness Study of Gardasil on Condyloma